Assessment of the Effects of D-003, a New Antiplatelet and Lipid-Lowering Compound, in Healthy Volunteers: A Phase I Clinical Study

Author： Castaño G.  

Publisher： Adis International

ISSN： 1174-5886

Source： Drugs in R&D, Vol.3, Iss.5, 2002-01, pp. : 337-348

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of D-003, a New Compound Purified from Sugarcane Wax, on Platelet Aggregation in Healthy Volunteers: A Randomised, Double-Blind Clinical Study

By Arruzazabala M.d.L.  

Clinical Drug Investigation, Vol. 23, Iss. 2, 2003-01 ,pp. : 107-118

Adis International

Access to resources Recommend Favorite

D 003: antiplatelet and cholesterol-lowering effects

By  

Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Effects of D-003 on the Lipid Profile of Patients with Type II Hypercholesterolaemia: A Phase II Clinical Study

By Castaño G.  

Clinical Drug Investigation, Vol. 23, Iss. 12, 2003-01 ,pp. : 789-802

Adis International

Access to resources Recommend Favorite

New lipid-lowering agents

By Wierzbicki Anthony S  

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 2, 2003-11 ,pp. : 365-376

Informa Healthcare

Access to resources Recommend Favorite

Comparison of the Lipid-Lowering Effects of Fluvastatin, Lovastatin and Simvastatin in Patients with Hyperlipoproteinaemia : An Internally Controlled Clinical Study

By Paragh G.   Balogh Z.   Kakuk G.   Kovacs P.  

Clinical Drug Investigation, Vol. 18, Iss. 3, 1999-09 ,pp. : 209-215

Adis International

Access to resources Recommend Favorite